Rationale for phosphodiesterase-4 inhibition as a treatment strategy for interstitial lung diseases associated with rheumatic diseases

By sjmartinez • December 25, 2024

Aringer M, Distler O, Hoffmann-Vold AM, Kuwana M, Prosch H, Volkmann ER. Rationale for phosphodiesterase-4 inhibition as a treatment strategy for interstitial lung diseases associated with rheumatic diseases. RMD Open. 2024 Dec 23;10(4):e004704. doi: 10.1136/rmdopen-2024-004704. PMID: 39719300.

Tags: Autoimmune Diseases, Publications, Pulmonary fibrosis, Rheumatology, Therapeutics

SUNRAY-02: a study of olomorasib combined with immunotherapy in stage II-III KRAS G12C-mutant non-small cell lung cancer after definitive therapy

Chaft J, Lee JM, Senan S, Neal JW, Nadal E, Negrao MV, Popat S, Garassino MC, Gray JE, Lee SH, Mazieres J, Thomas M, Benes[...]

Paget Disease of the Calvarium: A Case Report

Navabi K, Patel E. Paget Disease of the Calvarium: A Case Report. Cureus. 2026 Sep 25;18(9):e116917. doi: 10.7759/cureus.116917. PMID: 42928824; PMCID: PMC13695978.

Frailty Is Associated With Lower Urinary Tract Symptoms in Adults With and Without HIV

Abelman RA, Ma Y, Margolick JB, Erlandson KM, Greene M, Suskind AM, Taylor T, Rinaldo CR, Floris-Moore M, Chew KW, French AL, Markland AD, Stosor[...]